Drug Shortage Report for SOFLAX

Last updated on 2019-09-12 History
Report ID 83714
Drug Identification Number 02029529
Brand name SOFLAX
Common or Proper name SOFLAX
Company Name PHARMASCIENCE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) DOCUSATE SODIUM
Strength(s) 200MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 500
ATC code A06AA
ATC description DRUGS FOR CONSTIPATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-05-08
Estimated end date 2019-10-07
Actual end date 2019-09-09
Shortage status Resolved
Updated date 2019-09-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-09-12 French Compare
v3 2019-09-12 English Compare
v2 2019-05-09 French Compare
v1 2019-05-09 English Compare

Showing 1 to 4 of 4